Ticker brief
DHR DANAHER CORP
Consumer, Non-cyclical · Healthcare-Products
last close
$197.93
1 day
+2.2%
14 days
+11.7%
mkt cap
$140.1B
signals 14d
15
authors 14d
10
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-03 · now -0.70 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Stockspy1 | C | +0.01 | 4 | -0.26 |
| @SunriseTrader | B | -1.88 | 3 | +0.20 |
| @CrweWorld | C | · | 1 | +0.00 |
| @hughesanalytics | A | -0.29 | 1 | +0.20 |
| @SchwabNetwork | C | -1.14 | 1 | +0.00 |
| @ParadisLabs | A | +1.15 | 1 | +0.25 |
| @VladBastion | B | +1.88 | 1 | +0.35 |
| @SixSigmaCapital | B | -0.48 | 1 | +0.10 |
| @Apollo_21mil | B | +1.30 | 1 | -0.15 |
| @MacroAlphaHQ | A | +1.15 | 1 | -0.70 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-03 | @MacroAlphaHQ | -0.70 | Says DHR consensus strong buy and 236 target are damage control as stock hits resistance near 200. | — | tweet ↗ |
| 2026-07-02 | @SunriseTrader | +0.20 | Author raised DHR stops and notes 200MA within reach. | — | tweet ↗ |
| 2026-07-02 | @Stockspy1 | -0.09 | Mentions liked biotechs and preference for med equipment/chemicals. | — | tweet ↗ |
| 2026-07-01 | @SunriseTrader | +0.20 | Author holds DHR let-it-ride and made no stop changes. | +2.2% | tweet ↗ |
| 2026-07-01 | @Stockspy1 | -0.33 | Discloses long all three as they start to move. | +2.2% | tweet ↗ |
| 2026-06-28 | @Apollo_21mil | -0.15 | Author says they will not pay up for quality after several names were wrecked. | +0.9% | tweet ↗ |
| 2026-06-27 | @SixSigmaCapital | +0.10 | Discloses owning OUST and AMBA and lists healthcare/robotics ideas. | +0.9% | tweet ↗ |
| 2026-06-27 | @VladBastion | +0.35 | Healthcare led weekly performance while semis declined. | +0.9% | tweet ↗ |
| 2026-06-26 | @SunriseTrader | +0.20 | States DHR went ex-date and author still owns let-it-ride shares. | +0.9% | tweet ↗ |
| 2026-06-25 | @ParadisLabs | +0.25 | Health and biotech described as decent hedge with DHR and MRK outperforming. | +2.4% | tweet ↗ |
| 2026-06-25 | @SchwabNetwork | +0.00 | Segment offers example options trades and technical setups for JPM, DHR and MRK. | +2.4% | tweet ↗ |
| 2026-06-24 | @hughesanalytics | +0.20 | Notes anomaly chart showing big upside movers DHR, HD and UBER. | +4.8% | tweet ↗ |
| 2026-06-24 | @Stockspy1 | -0.24 | Says he still likes chemical-related names and still needs wet chemistry. | +4.8% | tweet ↗ |
| 2026-06-24 | @Stockspy1 | -0.39 | Buying a small amount of DHR, TMO, and AVTR. — Explicitly says he is buying all three chemical suppliers tied to health sciences research. | +4.8% | tweet ↗ |
| 2026-06-22 | @CrweWorld | +0.00 | Danaher schedules Q2 2026 earnings conference call. | +11.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.